Vanguard Group’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$40.1M Buy
2,906,386
+489,282
+20% +$11.5M ﹤0.01% 2287
2025
Q3
$59.1M Buy
2,417,104
+227,676
+10% +$5.54M ﹤0.01% 2080
2025
Q2
$50.6M Sell
2,189,428
-89,232
-4% -$2.35M ﹤0.01% 2113
2025
Q1
$61.5M Buy
2,278,660
+142,328
+7% +$5.37M ﹤0.01% 2006
2024
Q4
$114M Buy
2,136,332
+288,402
+16% +$15.3M ﹤0.01% 1814
2024
Q3
$84M Buy
1,847,930
+286,172
+18% +$12.4M ﹤0.01% 1951
2024
Q2
$65.4M Buy
1,561,758
+203,798
+15% +$9.57M ﹤0.01% 2044
2024
Q1
$51.1M Buy
1,357,960
+378,477
+39% +$8.24M ﹤0.01% 2158
2023
Q4
$10.5M Buy
979,483
+37,202
+4% +$322K ﹤0.01% 2919
2023
Q3
$9.5M Buy
942,281
+180,291
+24% +$2.08M ﹤0.01% 2918
2023
Q2
$9.04M Sell
761,990
-10,665
-1% -$143K ﹤0.01% 3002
2023
Q1
$9.35M Buy
772,655
+18,035
+2% +$300K ﹤0.01% 2973
2022
Q4
$9.94M Sell
754,620
-5,854
-0.8% -$85.7K ﹤0.01% 2949
2022
Q3
$10.3M Buy
760,474
+110,834
+17% +$1.48M ﹤0.01% 2940
2022
Q2
$7.93M Buy
649,640
+83,661
+15% +$990K ﹤0.01% 3112
2022
Q1
$8.12M Buy
565,979
+32,908
+6% +$538K ﹤0.01% 3264
2021
Q4
$10.5M Buy
533,071
+2,829
+0.5% +$59.3K ﹤0.01% 3174
2021
Q3
$11.5M Buy
530,242
+501,266
+1,730% +$14.4M ﹤0.01% 3158
2021
Q2
$723K Buy
+28,976
New +$645K ﹤0.01% 4207

Other funds holding JANX